Trinh et al. designed a CX3CR1 overexpressing (NKG2D) CAR-T expression and found that CAR-T cells infiltrated tumors at higher rates than control-activated T cells or IL-15-overexpressing NKG2D CAR-T cells in a liver cancer model [72]. The gene discussed is KLRK1; the disease is liver cancer.